Prostatype Genomics AB (publ) (STO:PROGEN)
Sweden · Delayed Price · Currency is SEK 0.9760
-0.0140 (-1.41%)
At close: Mar 27, 2026
Prostatype Genomics AB Market Cap
Prostatype Genomics AB has a market cap or net worth of 57.77 million as of March 27, 2026. Its market cap has increased by 84.89% in one year.
Market Cap
57.77M
Enterprise Value
48.70M
Revenue
594.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.98
Market Cap Chart
Since November 3, 2020, Prostatype Genomics AB's market cap has decreased from 92.30M to 57.77M, a decrease of -37.41%. That is a compound annual growth rate of -8.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 57.77M | 225.33% |
| Dec 30, 2025 | 17.76M | -76.14% |
| Dec 30, 2024 | 74.42M | 555.78% |
| Dec 29, 2023 | 11.35M | -76.58% |
| Dec 30, 2022 | 48.46M | -64.07% |
| Dec 30, 2021 | 134.89M | -28.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 132.39B |
| Getinge AB | 50.93B |
| Sectra AB | 43.16B |
| BioArctic AB | 28.14B |
| Pila Pharma AB | 69.35M |
| IDL Diagnostics AB | 65.88M |
| AcouSort AB | 63.07M |
| ScandiDos AB | 56.90M |